跳至主要内容
临床试验/IRCT20081202001479N7
IRCT20081202001479N7招募中4 期

Efficacy of Botulinum Toxin A Injection for Raynaud's Phenomenon and digital ulcers in patients with systemic sclerosis (scleroderma)

Mashhad University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Scleroderma diagnosis based on the American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR) criteria
  • age>18 years
  • Bilateral Raynaud's phenomenon with an intensity greater than 50 according to the Raynaud's condition score (RCS) questionnaire
  • ?Dysfunction of the arm and shoulder and arm more than 50 according to the Quick Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire
  • Pain intensity greater than 5 based on visual analog scale (VAS)

排除标准

  • Active infection in any of the hands
  • History of any botulinum toxin allergy
  • History of upper extremity vascular surgery
  • History of sympathectomy
  • Breast feeding

研究者

相似试验